{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T16:12:19Z","timestamp":1696954339930},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4,1]]},"DOI":"10.1093\/jac\/dki003","type":"journal-article","created":{"date-parts":[[2005,2,19]],"date-time":"2005-02-19T01:23:43Z","timestamp":1108776223000},"page":"579-582","source":"Crossref","is-referenced-by-count":8,"title":["Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175)"],"prefix":"10.1093","volume":"55","author":[{"given":"Keith","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Storey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Stubbings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony M.","family":"Hoyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne K.","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,4]]},"reference":[{"key":"key\n\t\t\t\t20171010184723_R1","doi-asserted-by":"crossref","unstructured":"Fujimura, T., Yamano, Y., Yoshida, I. et al. (2003). In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci. Antimicrobial Agents and Chemotherapy47, 923\u201331.","DOI":"10.1128\/AAC.47.3.923-931.2003"},{"key":"key\n\t\t\t\t20171010184723_R2","doi-asserted-by":"crossref","unstructured":"Malouin, F., Blais, J., Chamberland, S. et al. (2003). RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal \u03b2-lactamases. Antimicrobial Agents and Chemotherapy47, 658\u201364.","DOI":"10.1128\/AAC.47.2.658-664.2003"},{"key":"key\n\t\t\t\t20171010184723_R3","doi-asserted-by":"crossref","unstructured":"Huang, V., Brown, W. J. & Rybak, M. J. (2004). In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci. Antimicrobial Agents and Chemotherapy48, 2719\u201323.","DOI":"10.1128\/AAC.48.7.2719-2723.2004"},{"key":"key\n\t\t\t\t20171010184723_R4","unstructured":"Haas, D. W. & Kaiser, A. B. (1994). Antimicrobial prophylaxis of infections associated with foreign bodies. In Infections Associated with Indwelling Medical Devices, 2nd edn (Bisno, A. L. & Waldvogel, F. A. Eds), pp. 375\u201388. ASM Press, Washington DC, USA."},{"key":"key\n\t\t\t\t20171010184723_R5","unstructured":"Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy27, Suppl. D, 1\u201350."},{"key":"key\n\t\t\t\t20171010184723_R6","doi-asserted-by":"crossref","unstructured":"Ceri, H., Olson, M. E., Stremick, C. et al. (1999). The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. Journal of Clinical Microbiology37, 1771\u20136.","DOI":"10.1128\/JCM.37.6.1771-1776.1999"},{"key":"key\n\t\t\t\t20171010184723_R7","doi-asserted-by":"crossref","unstructured":"McDonald, P. J., Craig, W. A. & Kunin, C. M. (1977). Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. Journal of Infectious Diseases135, 217\u201323.","DOI":"10.1093\/infdis\/135.2.217"},{"key":"key\n\t\t\t\t20171010184723_R8","doi-asserted-by":"crossref","unstructured":"O'Neill, A. J., Cove, J. H. & Chopra, I. (2001). Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy47, 647\u201350.","DOI":"10.1093\/jac\/47.5.647"},{"key":"key\n\t\t\t\t20171010184723_R9","doi-asserted-by":"crossref","unstructured":"Komatsuzawa, H., Choi, G. H., Ohta, K. et al. (1999). Cloning and characterization of a gene, pbpF, encoding a new penicillin-binding protein, PBP2B, in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy43, 1578\u201383.","DOI":"10.1128\/AAC.43.7.1578"},{"key":"key\n\t\t\t\t20171010184723_R10","doi-asserted-by":"crossref","unstructured":"Lu, W. P., Sun, Y. P., Bauer, M. D. et al. (1999). Penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus: kinetic characterization of its interactions with \u03b2-lactams using electrospray mass spectrometry. Biochemistry38, 6537\u201346.","DOI":"10.1021\/bi990025e"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/55\/4\/579\/2399202\/dki003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T21:25:54Z","timestamp":1586121954000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/55\/4\/579\/800997\/Antistaphylococcal-activity-of-the-novel"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,1]]},"references-count":10,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,4]]},"published-print":{"date-parts":[[2005,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki003","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,4]]},"published":{"date-parts":[[2005,4,1]]}}}